Can Stress-Blockers help fight melanoma? early trial launches
Disease control
Recruiting now
This early-phase trial tests whether adding two stress-blocking drugs—naltrexone and propranolol—to standard immunotherapy (ipilimumab and nivolumab) is safe for people with advanced melanoma. The study aims to find the best dose and check for side effects in 12 participants. If …
Phase: PHASE1 • Sponsor: Sarah Weiss • Aim: Disease control
Last updated Jun 26, 2026 17:47 UTC